How much is incruse ellipta without insurance?

Incruse Ellipta (fluticasone furoate/umeclidinium) is a brand‑name inhaler used for COPD. Because it’s still under patent, there isn’t a generic version yet, so the retail price tends to be high.

Typical out‑of‑pocket cost (no insurance)

• U.S.: Roughly $800–$1,000 per month (depending on the pharmacy, region, and any pharmacy‑specific discounts).
• U.K.: Often in the £250–£350 range per month (again, varies by pharmacy).

These are approximate figures that come from pharmacy retail prices. Your actual bill could be slightly higher or lower for a number of reasons:

How to get a more accurate estimate

1. Call your local pharmacy – ask for the list price for a single inhaler, then multiply by the number of inhalers you’ll need per month (usually 1–2).
2. Use online discount tools – sites like GoodRx or RxSaver can show you the lowest price available at pharmacies in your area.
3. Ask about the manufacturer card – you can request a “Pfizer savings card” at the pharmacy; it often provides a direct discount at the register.
4. Check for assistance programs – if you’re eligible for the Pfizer Patient Assistance Program (or a similar program), you might be able to get the medication free or at a very low cost.

Bottom line

Without insurance, expect to pay roughly $800–$1,000 per month for Incruse Ellipta in the U.S., but you can usually shave off a significant amount with discount cards, coupons, or manufacturer assistance. If the cost is a barrier, it’s worth exploring these options or speaking with your clinician about alternative therapies that might have lower out‑of‑pocket costs.